Synthego Launches High-Performance Molecular Reagents for Clinical and Molecular Diagnostics

REDWOOD CITY, CA – November 10, 2025

Synthego, a leading provider of CRISPR solutions, has announced a strategic expansion of its product offerings with the launch of a new portfolio of high-performance molecular reagents. Building on its established leadership in CRISPR gene editing, Synthego now delivers essential PCR enzymes, RNA synthesis tools, and advanced isothermal amplification kits designed to meet the stringent requirements of diagnostic laboratories as well as the evolving needs of molecular biology research. The launch addresses the growing demand for robust solutions designed to support the full spectrum of molecular biology and diagnostics workflows and accelerate the path from discovery to validation.

With these molecular reagent solutions, Synthego empowers scientists, clinicians, and researchers to address challenges such as assay sensitivity, workflow scalability, and reproducible performance across a broad range of sample types. These solutions are developed to provide the accuracy, reliability, and consistency critical for confident clinical decision-making, research innovation, and scalable, high-throughput testing. Additionally, Synthego offers product customization - including lyophilization - to fit seamlessly into customer-optimized workflows, supporting everything from complex molecular assays to routine bench science.

By expanding its expertise into these foundational areas, Synthego reaffirms its commitment to equipping the scientific community with the critical tools necessary to drive innovation and achieve breakthroughs in genomics, therapeutics, and molecular and clinical diagnostics.

Learn more about Synthego’s molecular diagnostics and molecular biology products.